EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chronic oral dosing of cannabidiol and cannabidiolic acid full-spectrum hemp oil extracts has no adverse effects in horses: a pharmacokinetic and safety study

Tongxin Charlotte Wang, Joseph J Wakshlag, Mason C Jager, Wayne S Schwark, Nathalie L Trottier, Jacqueline M Chevalier iD, Garett Pearson, Marta Cercone iD

American Journal of Veterinary Research · 2025

DOI: 10.2460/ajvr.24.08.0235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Tongxin Charlotte Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY. Hauptthemen laut MEDLINE: Cannabidiol, Cannabis, Cannabinoids, Plant Oils. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To compare the pharmacokinetics of cannabidiol (CBD) and cannabidiolic acid (CBDA) in horses and to evaluate the safety of their chronic administration. METHODS CBD- and CBDA-rich oil (1 mg/kg) were administered orally twice daily to 7 adult horses over 6 weeks in a randomized, crossover design with a 2-week washout period. A 12-hour pharmacokinetic analysis was conducted on day 1 of each 6-week trial, followed by the measurement of peak and trough concentrations at weeks 1, 2, 4, and 6. The cannabinoids safety was assessed via daily physical examination, periodic bloodwork, and liver biopsy at the beginning and end of the study. RESULTS 12-hour pharmacokinetics revealed a higher maximum serum concentration (103 vs 12 ng/mL) and greater area under the curve (259 vs 62 ng·h/mL) for CBDA when compared to CBD. Cannabidiolic acid nadir and peak serum levels over time ranged from 46 to 122 ng/mL, which was higher than CBD (12 to 38 ng/mL). Complete blood count and serum chemistry revealed no clinically relevant changes with either CBD or CBDA. No significant abnormalities were detected on liver ultrasonographic and histopathologic evaluation on day 0 and after both phases of the study. CONCLUSIONS A dose of either 1 mg/kg of CBD or CBDA administered long term appears safe; however, CBDA serum concentrations suggest superior absorption/retention. CLINICAL RELEVANCE Chronic cannabinoid supplementation in horses is safe. Considering the higher absorption of CBDA, its use is recommended to evaluate the therapeutic efficacy of this common hemp derived cannabinoid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolCannabisCannabinoidsPlant OilsPlant ExtractsAnimalsHorsesCross-Over StudiesAdministration, OralMaleFemaleArea Under Curve

Stichwörter der Autor:innen

cannabidiolcannabidiolic acidhorsepharmacokineticsafety

Substanzen

CannabidiolCannabinoidscannabidiolic acidPlant OilsPlant Extracts

Autor:innen und Institutionen

  • Department of Animal Science, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY.
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY.
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY.
  • Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, NY.

ORCID-Profile: Jacqueline M Chevalier, Marta Cercone

Zitieren

APA

Wang, T. C., Wakshlag, J. J., Jager, M. C., Schwark, W. S., Trottier, N. L., Chevalier, J. M., Pearson, G., & Cercone, M. (2025). Chronic oral dosing of cannabidiol and cannabidiolic acid full-spectrum hemp oil extracts has no adverse effects in horses: a pharmacokinetic and safety study. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.08.0235

Vancouver

Wang TC, Wakshlag JJ, Jager MC, Schwark WS, Trottier NL, Chevalier JM, et al. Chronic oral dosing of cannabidiol and cannabidiolic acid full-spectrum hemp oil extracts has no adverse effects in horses: a pharmacokinetic and safety study. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.24.08.0235

BibTeX
@article{Wang2025,
  author = {Wang, Tongxin Charlotte and Wakshlag, Joseph J and Jager, Mason C and Schwark, Wayne S and Trottier, Nathalie L and Chevalier, Jacqueline M and Pearson, Garett and Cercone, Marta},
  title = {Chronic oral dosing of cannabidiol and cannabidiolic acid full-spectrum hemp oil extracts has no adverse effects in horses: a pharmacokinetic and safety study},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  doi = {10.2460/ajvr.24.08.0235}
}
Kostenlos starten →